603456 九洲藥業
按盤價 
14.890 -1.650 (-9.976%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.954 | 8.459 | 7.131 | 15.020 | 18.659 |
| 總資產報酬率 ROA (%) | 1.624 | 6.719 | 5.515 | 11.012 | 12.320 |
| 投入資產回報率 ROIC (%) | 1.874 | 7.872 | 6.439 | 13.196 | 15.313 | 邊際利潤分析 |
| 銷售毛利率 (%) | 36.372 | 36.852 | 33.783 | 37.656 | 34.660 |
| 營業利潤率 (%) | 18.310 | 16.791 | 14.188 | 21.287 | 20.347 |
| 息稅前利潤/營業總收入 (%) | 18.938 | 16.391 | 12.649 | 20.006 | 18.689 |
| 淨利潤/營業總收入 (%) | 14.015 | 13.226 | 11.764 | 18.673 | 16.914 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.517 | 132.144 | 127.672 | 105.670 | 105.420 |
| 價值變動淨收益/利潤總額(%) | 2.302 | 0.387 | -1.113 | -1.640 | -3.003 |
| 營業外收支淨額/利潤總額(%) | 0.009 | -0.598 | -0.217 | 0.413 | -0.371 | 償債能力分析 |
| 流動比率 (X) | 3.828 | 3.510 | 2.967 | 3.812 | 1.804 |
| 速動比率 (X) | 2.786 | 2.613 | 2.025 | 2.629 | 0.891 |
| 資產負債率 (%) | 15.444 | 17.093 | 22.626 | 21.369 | 32.119 |
| 帶息債務/全部投入資本 (%) | 1.430 | 1.646 | 6.638 | 6.929 | 11.708 |
| 股東權益/帶息債務 (%) | 6,715.057 | 5,819.316 | 1,362.182 | 1,301.104 | 720.957 |
| 股東權益/負債合計 (%) | 543.671 | 481.360 | 339.070 | 364.874 | 208.389 |
| 利息保障倍數 (X) | 30.216 | -54.571 | -8.385 | -14.610 | -11.810 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 75.648 | 72.396 | 75.262 | 53.230 | 47.541 |
| 存貨周轉天數 (天) | 169.444 | 173.065 | 204.811 | 208.092 | 187.365 |
| 備註： | 即時報價更新時間為 24/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
